Growing community of inventors

Vienna, Austria

Dirk Voelkel

Average Co-Inventor Count = 4.93

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Dirk VoelkelRandolf Kerschbaumer (4 patents)Dirk VoelkelFriedrich Scheiflinger (3 patents)Dirk VoelkelPatrice Douillard (3 patents)Dirk VoelkelHanspeter Rottensteiner (2 patents)Dirk VoelkelAlfred Weber (2 patents)Dirk VoelkelGerhard Antoine (2 patents)Dirk VoelkelAndrea Engelmaier (2 patents)Dirk VoelkelMichael Thiele (2 patents)Dirk VoelkelRobert Pachlinger (2 patents)Dirk VoelkelGeert Mudde (1 patent)Dirk VoelkelAlexander Schinagl (1 patent)Dirk VoelkelHartmut Ehrlich (1 patent)Dirk VoelkelRandolf J Kerschbaumer (0 patent)Dirk VoelkelC Geert Mudde (0 patent)Dirk VoelkelDirk Voelkel (6 patents)Randolf KerschbaumerRandolf Kerschbaumer (16 patents)Friedrich ScheiflingerFriedrich Scheiflinger (76 patents)Patrice DouillardPatrice Douillard (4 patents)Hanspeter RottensteinerHanspeter Rottensteiner (34 patents)Alfred WeberAlfred Weber (27 patents)Gerhard AntoineGerhard Antoine (11 patents)Andrea EngelmaierAndrea Engelmaier (6 patents)Michael ThieleMichael Thiele (4 patents)Robert PachlingerRobert Pachlinger (2 patents)Geert MuddeGeert Mudde (15 patents)Alexander SchinaglAlexander Schinagl (2 patents)Hartmut EhrlichHartmut Ehrlich (1 patent)Randolf J KerschbaumerRandolf J Kerschbaumer (0 patent)C Geert MuddeC Geert Mudde (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Baxalta Gmbh (6 from 151 patents)

2. Takeda Pharmaceutical Company Limited (3 from 1,177 patents)


6 patents:

1. 11999798 - Anti-factor IX padua antibodies

2. 11402388 - Anti-MIF immunohistochemistry

3. 11098132 - Anti-factor IX Padua antibodies

4. 10626166 - Detection of CHO-MIF contaminations

5. 9958456 - OxMIF as a diagnostic marker

6. 9465037 - Characterization of CHO-MIF gene and protein, and use thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…